Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.08
0.076.93%
At close: -
$1.05
-0.03-2.78%
After Hours: 6:29 PM EDT
Comments
Loading...
Geovax Labs (GOVX) Forecast
NewsEarningsGeovax Labs (GOVX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Geovax Labs Stock Price, Quotes and Forecasts | NASDAQ:GOVX | Benzinga
Explore Geovax Labs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GOVX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Geovax Labs (GOVX) stock?
You can purchase shares of Geovax Labs (NASDAQ:GOVX) through any online brokerage.
Who are Geovax Labs (GOVX) competitors?
Other companies in Geovax Labs’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Can Fite Biofarma (AMEX:CANF), GlycoMimetics (NASDAQ:GLYC) and BioLine Rx (NASDAQ:BLRX).
What is the forecast, or price target, for Geovax Labs (GOVX) stock?
Geovax Labs has a consensus price target of $11.25.
What is the current price for Geovax Labs (GOVX)?
The stock price for Geovax Labs (NASDAQ: GOVX) is $1.05 last updated May 27, 2025 at 6:29 PM EDT.
Does Geovax Labs (GOVX) pay a dividend?
There are no upcoming dividends for Geovax Labs.
When is Geovax Labs (NASDAQ:GOVX) reporting earnings?
Geovax Labs’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is Geovax Labs (GOVX) going to split?
There is no upcoming split for Geovax Labs.
What sector and industry does Geovax Labs (GOVX) operate in?
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
